The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2022

Filed:

May. 09, 2019
Applicants:

Hefei Industrial Pharmaceutical Institute Co., Ltd., Anhui, CN;

Hefei Amvite Pharmaceutical Co., Ltd, Anhui, CN;

Inventors:

Guangwei He, Anhui, CN;

Zhaoxing Chu, Anhui, CN;

Qinlong Xu, Anhui, CN;

Jiajia Mo, Anhui, CN;

Yan Zhao, Anhui, CN;

Lincui Bian, Anhui, CN;

Yuanfeng Gu, Anhui, CN;

Li Shao, Anhui, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/69 (2006.01); A61P 17/00 (2006.01); A61K 9/00 (2006.01); A61K 31/519 (2006.01);
U.S. Cl.
CPC ...
A61K 31/69 (2013.01); A61K 9/0014 (2013.01); A61K 31/519 (2013.01); A61P 17/00 (2018.01);
Abstract

The disclosure relates to the field of pharmaceutical technology, in particular, to a compound pharmaceutical composition for treating skin inflammatory diseases, which is characterized in that an active ingredient of the compound pharmaceutical of the disclosure is composed of tofacitinib and crisaborole, and the composition has a stronger therapeutic effect and a lower dosage with a significant synergistic therapeutic effect. The pharmaceutical composition of the disclosure can be used to treat skin inflammatory diseases.


Find Patent Forward Citations

Loading…